The above findings are sufficient to suggest that DEK may somehow regulate PINK1-Parkin-mediated mitophagy and NLRP3 inflammasome and that targeting the DEK pathway could be exploited therapeutically in airway inflammation and asthma. The gene discussed is DEK; the disease is inflammatory response.